BSX Q2 2025 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.1B+22.8% YoY

Gross Profit

$3.4B67.7% margin

Operating Income

$819M16.2% margin

Net Income

$793M15.7% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.1B

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$41.6B

Total Liabilities

$18.9B

Stockholders' Equity

$22.4B

Cash & Equivalents

$534M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.1B	$4.1B	+22.8%
Gross Profit	$3.4B	$2.6B	+32.5%
Operating Income	$819M	$747M	+9.6%
Net Income	$793M	$324M	+144.8%

Revenue Segments

Cardiovascular

$3.3B66%

MedSurg

$1.7B34%

Geographic Segments

UNITED STATES

$2.0B53%

Non-US

$1.8B47%